Niacin to Improve Blood Flow in People With Sickle Cell Disease

NCT00508989 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Niacin-ER
DRUG: Placebo
DRUG: L-NMMA
DRUG: Acetylcholine

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)